157 related articles for article (PubMed ID: 34032953)
1. Structured Evaluation of Rehabilitation Programs Outcomes in Psychiatry: Application of a Recovery-Centered Model.
Vanzetto S; Zabotto M; Fasciana F; Varinelli A; Cirnigliaro G; Ferrara L; Dell'Osso B; Viganò C
Psychiatr Q; 2021 Dec; 92(4):1513-1530. PubMed ID: 34032953
[TBL] [Abstract][Full Text] [Related]
2. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study.
García Álvarez JC; González Sánchez L; García Resa E; Bonete Llácer JM; Román Rodríguez A; Pecino Esquerdo B; Pérez Martínez E
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):10-17. PubMed ID: 31933402
[No Abstract] [Full Text] [Related]
3. Longitudinal analysis of statistical and clinically significant psychosocial change following mental health rehabilitation.
Maxwell A; Tsoutsoulis K; Menon Tarur Padinjareveettil A; Zivkovic F; Rogers JM
Disabil Rehabil; 2019 Dec; 41(24):2927-2939. PubMed ID: 29978733
[No Abstract] [Full Text] [Related]
4. Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit.
Gilbert JL; Nelson LA; Kriz CR; Liu Y; Iuppa CA; Diefenderfer LA; Elliott ESR; Sommi RW
Psychopharmacol Bull; 2019 Jun; 49(2):8-16. PubMed ID: 31308578
[TBL] [Abstract][Full Text] [Related]
5. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
6. Goal-oriented cognitive rehabilitation for early-stage Alzheimer's and related dementias: the GREAT RCT.
Clare L; Kudlicka A; Oyebode JR; Jones RW; Bayer A; Leroi I; Kopelman M; James IA; Culverwell A; Pool J; Brand A; Henderson C; Hoare Z; Knapp M; Morgan-Trimmer S; Burns A; Corbett A; Whitaker R; Woods B
Health Technol Assess; 2019 Mar; 23(10):1-242. PubMed ID: 30879470
[TBL] [Abstract][Full Text] [Related]
7. Gender impact on the outcome of rehabilitation programs in psychiatry: Brief report from a metropolitan residential rehabilitative service.
Cafaro R; Rosti CAM; Cerolini L; Varinelli A; Charitos S; Magnotti R; Benatti B; Dell'Osso B; Viganò CA
Front Psychiatry; 2023; 14():1145940. PubMed ID: 37113552
[TBL] [Abstract][Full Text] [Related]
8. Recovery outcomes of schizophrenia patients treated with paliperidone palmitate in a community setting: patient and provider perspectives on recovery.
Williams W; McKinney C; Martinez L; Benson C
J Med Econ; 2016; 19(5):469-76. PubMed ID: 26671481
[TBL] [Abstract][Full Text] [Related]
9. Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post discharge.
Parker S; Arnautovska U; Siskind D; Dark F; McKeon G; Korman N; Harris M
Epidemiol Psychiatr Sci; 2020 Mar; 29():e109. PubMed ID: 32157987
[TBL] [Abstract][Full Text] [Related]
10. Intensity and continuity of services and functional outcomes in the rehabilitation of persons with schizophrenia.
Brekke JS; Ansel M; Long J; Slade E; Weinstein M
Psychiatr Serv; 1999 Feb; 50(2):248-56. PubMed ID: 10030485
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study.
Nielsen J; Jensen SO; Friis RB; Valentin JB; Correll CU
Schizophr Bull; 2015 May; 41(3):627-36. PubMed ID: 25180312
[TBL] [Abstract][Full Text] [Related]
12. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome.
Olagunju AT; Clark SR; Baune BT
Aust N Z J Psychiatry; 2019 Jun; 53(6):509-527. PubMed ID: 30957510
[TBL] [Abstract][Full Text] [Related]
13. Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs).
Brugnoli R; Rapinesi C; Kotzalidis GD; Marcellusi A; Mennini FS; De Filippis S; Carrus D; Ballerini A; Francomano A; Ducci G; Del Casale A; Girardi P
Riv Psichiatr; 2016; 51(2):47-59. PubMed ID: 27183509
[TBL] [Abstract][Full Text] [Related]
14. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
Vacheron MN; Veyrat-Masson H; Wehbe E
Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
[TBL] [Abstract][Full Text] [Related]
15. The VADO approach in psychiatric rehabilitation: a randomized controlled trial.
Gigantesco A; Vittorielli M; Pioli R; Falloon IR; Rossi G; Morosini P
Psychiatr Serv; 2006 Dec; 57(12):1778-83. PubMed ID: 17158494
[TBL] [Abstract][Full Text] [Related]
16. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
17. [Psychosocial rehabilitation at the dawn of the 21st century: III: Interdisciplinary evaluation method and bio-psycho-social schedule].
Grasset F; Pomini V; Favrod J; Orita A; Veillon H; Cucchia AT
Rev Med Suisse Romande; 2004 Apr; 124(4):199-203. PubMed ID: 15209050
[TBL] [Abstract][Full Text] [Related]
18. Recovery-Oriented Outcomes Associated with Long-Acting Injectable Antipsychotics in an Urban Safety-Net Population.
Yoshimatsu K; Elser A; Thomas M; Dilley J; Barnes D; Ballinger A; Wozniak S; Mangurian C
Community Ment Health J; 2019 Aug; 55(6):979-982. PubMed ID: 31102164
[TBL] [Abstract][Full Text] [Related]
19. Assessing need for pharmacist involvement to improve care coordination for patients on LAI antipsychotics transitioning from hospital to home: A work system approach.
Abraham O; Myers MN; Brothers AL; Montgomery J; Norman BA; Fabian T
Res Social Adm Pharm; 2017; 13(5):1004-1013. PubMed ID: 28811014
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
